UBS AM’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
91,862
+27,446
| +43% | +$591K | ﹤0.01% | 2147 |
|
|
2025
Q1 | $1.47M | Sell |
64,416
-6,270
| -9% | -$143K | ﹤0.01% | 2142 |
|
|
2024
Q4 | $1.84M | Buy |
70,686
+8,258
| +13% | +$214K | ﹤0.01% | 2094 |
|
|
2024
Q3 | $1.56M | Sell |
62,428
-1,271
| -2% | -$31.8K | ﹤0.01% | 2174 |
|
|
2024
Q2 | $1.37M | Buy |
63,699
+20,779
| +48% | +$445K | ﹤0.01% | 2204 |
|
|
2024
Q1 | $796K | Hold |
42,920
| – | – | ﹤0.01% | 2119 |
|
|
2023
Q4 | $697K | Buy |
42,920
+4,736
| +12% | +$77K | ﹤0.01% | 2207 |
|
|
2023
Q3 | $527K | Hold |
38,184
| – | – | ﹤0.01% | 2276 |
|
|
2023
Q2 | $831K | Hold |
38,184
| – | – | ﹤0.01% | 2088 |
|
|
2023
Q1 | $831K | Buy |
38,184
+3,041
| +9% | +$66.1K | ﹤0.01% | 2088 |
|
|
2022
Q4 | $640K | Hold |
35,143
| – | – | ﹤0.01% | 2073 |
|
|
2022
Q3 | $800K | Sell |
35,143
-6,231
| -15% | -$142K | ﹤0.01% | 2100 |
|
|
2022
Q2 | $571K | Buy |
41,374
+10,258
| +33% | +$142K | ﹤0.01% | 2261 |
|
|
2022
Q1 | $707K | Hold |
31,116
| – | – | ﹤0.01% | 2310 |
|
|
2021
Q4 | $1.16M | Hold |
31,116
| – | – | ﹤0.01% | 2134 |
|
|
2021
Q3 | $1.32M | Sell |
31,116
-1,165
| -4% | -$49.3K | ﹤0.01% | 2028 |
|
|
2021
Q2 | $1.44M | Buy |
32,281
+3,781
| +13% | +$168K | ﹤0.01% | 2005 |
|
|
2021
Q1 | $1.03M | Buy |
28,500
+2,400
| +9% | +$86.4K | ﹤0.01% | 2078 |
|
|
2020
Q4 | $1.04M | Buy |
+26,100
| New | +$1.04M | ﹤0.01% | 1969 |
|